Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in …
NL Albert, M Weller, B Suchorska, N Galldiks… - Neuro …, 2016 - academic.oup.com
This guideline provides recommendations for the use of PET imaging in gliomas. The review
examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) …
examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) …
PET/MRI: where might it replace PET/CT?
EC Ehman, GB Johnson… - Journal of Magnetic …, 2017 - Wiley Online Library
Simultaneous positron emission tomography and MRI (PET/MRI) is a technology that
combines the anatomic and quantitative strengths of MR imaging with physiologic …
combines the anatomic and quantitative strengths of MR imaging with physiologic …
[HTML][HTML] Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG …
These joint practice guidelines, or procedure standards, were developed collaboratively by
the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and …
the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and …
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group
Summary Response Assessment in Neuro-Oncology (RANO) response criteria have been
established and were updated in 2023 for MRI-based response evaluation of diffuse …
established and were updated in 2023 for MRI-based response evaluation of diffuse …
[HTML][HTML] PET imaging in neuro-oncology: An update and overview of a rapidly growing area
Simple Summary Positron emission tomography (PET) is a functional imaging technique
which plays an increasingly important role in the management of brain tumors. Owing …
which plays an increasingly important role in the management of brain tumors. Owing …
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-l-tyrosine PET
N Galldiks, V Dunkl, G Stoffels, M Hutterer… - European journal of …, 2015 - Springer
Purpose The follow-up of glioblastoma patients after radiochemotherapy with conventional
MRI can be difficult since reactive alterations to the blood–brain barrier with contrast …
MRI can be difficult since reactive alterations to the blood–brain barrier with contrast …
Multimodality brain tumor imaging: MR imaging, PET, and PET/MR imaging
JR Fink, M Muzi, M Peck, KA Krohn - Journal of Nuclear Medicine, 2015 - Soc Nuclear Med
Standard MR imaging and CT are routinely used for anatomic diagnosis in brain tumors.
Pretherapy planning and posttreatment response assessments rely heavily on gadolinium …
Pretherapy planning and posttreatment response assessments rely heavily on gadolinium …
Current status of PET imaging in neuro-oncology
Over the past decades, a variety of PET tracers have been used for the evaluation of patients
with brain tumors. For clinical routine, the most important clinical indications for PET imaging …
with brain tumors. For clinical routine, the most important clinical indications for PET imaging …
Performance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis
V Dunet, A Pomoni, A Hottinger… - Neuro …, 2015 - academic.oup.com
Background For the past decade 18F-fluoro-ethyl-l-tyrosine (FET) and 18F-fluoro-deoxy-
glucose (FDG) positron emission tomography (PET) have been used for the assessment of …
glucose (FDG) positron emission tomography (PET) have been used for the assessment of …
Lessons from anti–vascular endothelial growth factor and anti–vascular endothelial growth factor receptor trials in patients with glioblastoma
Treatment of glioblastoma (GBM), the most common primary malignant brain tumor in adults,
remains a significant unmet need in oncology. Historically, cytotoxic treatments provided …
remains a significant unmet need in oncology. Historically, cytotoxic treatments provided …